BOSTON (AP) — BOSTON (AP) — Pieris Pharmaceuticals Inc. (PIRS) on Wednesday reported a loss of $4.9 million in its first quarter.

On a per-share basis, the Boston-based company said it had a loss of $3.95.

The biopharmaceutical company posted revenue of $53,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PIRS at https://www.zacks.com/ap/PIRS